Zepbound

Active Ingredient(s): Tirzepatide
FDA Approved: * November 8, 2023
Pharm Company: * ELI LILLY AND CO
Category: Diabetes
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zepbound 15 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2457
Labeler:
Eli Lilly and Company
Zepbound 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2460
Labeler:
Eli Lilly and Company
Zepbound 10 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2471
Labeler:
Eli Lilly and Company
Zepbound 7.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2484
Labeler:
Eli Lilly and Company
Zepbound 5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2495
Labeler:
Eli Lilly and Company
Zepbound 2.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-2506
Labeler:
Eli Lilly and Company

Related Brands

Drugs with the same active ingredients